Gelonghui, March 15, 丨 Chuangmei Pharmaceutical (02289.HK) announced that the board of directors meeting will be held on March 28, 2024 (Thursday) to review and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and consider recommending payment of a final dividend (if any).
创美药业(02289.HK)拟3月28日举行董事会会议批准全年业绩
Chuangmei Pharmaceutical (02289.HK) plans to hold a board meeting on March 28 to approve the annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.